Cargando…
Phosphodiesterase‐5 Inhibitor Therapy for Left Ventricular Assist Device Patients: More Data, More Questions
Autores principales: | Gulati, Gaurav, Kiernan, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660721/ https://www.ncbi.nlm.nih.gov/pubmed/32648504 http://dx.doi.org/10.1161/JAHA.120.017585 |
Ejemplares similares
-
Phosphodiesterase‐5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure
por: Papathanasiou, Maria, et al.
Publicado: (2023) -
Phosphodiesterase type 5 inhibitors after left ventricular assist device: no free lunch?
por: Grandin, E. Wilson, et al.
Publicado: (2021) -
Increased bleeding risk with phosphodiesterase‐5 inhibitors after left ventricular assist device implantation
por: Jakstaite, Aiste‐Monika, et al.
Publicado: (2021) -
Massive retroperitoneal hemorrhage after external shock wave lithotripsy in a patient with a left ventricular assist device
por: Gulati, Gaurav, et al.
Publicado: (2019) -
902. Selection of Antibiotics for Prophylaxis of Left Ventricular Assist Device Surgical Infections: More is Not More
por: Nguyen, Peter T, et al.
Publicado: (2020)